Oramed Pharmaceuticals Stock Price - ORMP

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.10 -1.93% 5.08 5.29 5.01 5.26 5.18 18:41:35
Bid Price Ask Price Spread Spread % News
5.03 5.60 0.57 10.18% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
493 88,150 $ 5.12 $ 451,670 204,784 1.84 - 7.55
Last Trade Time Type Quantity Stock Price Currency
16:00:00 200 $ 5.08 USD

Oramed Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 90.10M 17.74M $ -12.73M -0.82 - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Oramed Pharmaceuticals News

Date Time Source News Article
1/23/202008:00PR Newswire (US)Oramed Elects Dr. Alexander Fleming to Scientific Advisory..
1/21/202014:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
1/21/202007:25PR Newswire (US)Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board
1/09/202015:58Edgar (US Regulatory)Quarterly Report (10-q)
1/09/202007:00PR Newswire (US)Oramed Pharmaceuticals Issues Letter to Shareholders
12/11/201916:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
12/06/201906:02Edgar (US Regulatory)Current Report Filing (8-k)

Latest ORMP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ORMP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.185.715.015.41133,752-0.10-1.93%
1 Month5.275.884.525.18136,125-0.19-3.61%
3 Months3.177.551.844.84248,0151.9160.25%
6 Months3.707.551.844.51135,6391.3837.3%
1 Year3.437.551.844.2198,3051.6548.1%
3 Years6.2811.341.845.5758,044-1.20-19.11%
5 Years4.8511.341.846.6979,5590.234.74%

Oramed Pharmaceuticals Description

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
Your Recent History
NASDAQ
ORMP
Oramed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200125 02:59:01